IRB Barcelona launches a campaign entitled “Future” to increase public awareness of biomedical research Blog Post

Today the Institute for Research in Biomedicine (IRB Barcelona) has launched a fundraising campaign called “Futur” (#IRBfutur). The campaign, which will run for two months, seeks to raise public awareness of the role that biomedical researchplays in advancing medicine, and the need to train scientists to ensure they can make the discoveries that may one day save our lives. The initiative aims to raise 25,000 euros to fund the first year of a PhD student at IRB Barcelona. The campaign is part of “Giving Tuesday”, a day devoted to charitable donations, which this year falls on Tuesday 29 November.

 

IRB Barcelona scientist Eduard Batlle wins the 2016 Carmen and Severo Ochoa Prize Blog Post

Coordinator of the Oncology Programme at the Institute for Research in Biomedicine (IRB Barcelona) and ICREA research professor Eduard Batlle has won the 2016 Carmen y Severo Ochoa Prize. Presented by the Fundación Carmen and Severo Ochoa since 1995, these awards recognise molecular biology research undertaken by scientists in Spain. The prize presentation ceremony will be held on Wednesday 16 November at the Residencia de Estudiantes in Madrid.

 

IRB Barcelona will bring together 300 young biomedical researchers at the 1st Enable symposium Blog Post

In November 2017, Barcelona will be the first European city to host the 300 young international biomedical researchers, mostly PhD students, who will be participating in the inaugural ENABLE symposium, an initiative promoted by the Institute for Research in Biomedicine (IRB Barcelona). This project was awarded 500,000 euros through the “Celebrating European Science” section of the EU’s Horizon 2020 Programme. The event in Barcelona will be the first of four yearly gatherings, the last one to be held in 2020, that seek to train the next generation of leading biomedical scientists in Europe.

 

IRB Barcelona intensifies its research on cancer with two new recruits Blog Post

Biologist and ICREA Research Professor Núria López-Bigas will join the Institute for Research in Biomedicine (IRB Barcelona) at the Barcelona Science Park (PCB) in November as a new Group Leader. Her laboratory brings the number of research groups at IRB Barcelona to 23, a number which will grow again in March 2017 with the arrival of Fran Supek another researcher in the bioinformatics and genomics of cancer.

 

The Barcelona Science Park hosts a bilateral meeting between Scandinavian and Spanish EIT Health partners Blog Post

More than 60 people from 42 different EIT Health partners and third parties from Spain and Scandinavia met last week in Barcelona at the bilateral meeting, organized by these two regional CLCs. This is the second bilateral event organized in Barcelona, the first one took place last June and the invited CLC was the French one. EIT Health has nodes in Spain, France, Uk-Ireland, Belgium-Netherlands, Sweden and Scandinavia. EIT Health Spain, based at the Barcelona Science Park (PCB), is made up of 18 organizations: companies, universities, research centers, hospitals and technology centers. 

 

Stat-Diagnostica attracts Siemens Venture Capital as a new investor Blog Post

Medical diagnostics company Stat-Diagnostica, based at the Barcelona Science Park, has closed an extension of its Series C financing with Siemens Venture Capital. Led by Gilde Healthcare, the Series C financing round also drew participation from existing investors, including Kurma Partners, Ysios Capital, Idinvest Partners, Boehringer Ingelheim Venture Fund, Caixa Capital Risc, and Axis. The additional proceeds will be used to support the 2017 European launch of its DiagCORE Near Patient Testing system. 

 

Developmental biology offers the key to finding solutions for paediatric cancer, metastasis, and regeneration Blog Post

From today and until Wednesday,  around 20 speakers from around the world and 150 participants will debate cutting-edge research into plasticity and cell migration—two key aspects in paediatric cancer, metastasis, and regeneration, at the Institut d’Estudis Catalans on the occasion of the 18th Barcelona Biomed Conference, an event organised by the Institute for Research in Biomedicine (IRB Barcelona) –based at PCB– with the support of the BBVA Foundation.

 

IBEC, ISGlobal and Bioiberica join forces to study new strategies based on nanomedicine to combat malaria Blog Post

The Institute for Bioengineering of Catalonia (IBEC), the Barcelona Institute for Global Health (ISGlobal) and the biotech firm Bioiberica have signed a partnership agreement to study the development of new compounds derived from heparin to combat malaria. The partnership, which was officially announced this morning at the international Biospain meeting held in Bilbao.